Abstract
This study investigated the beneficial effects and mechanism of action of the juice of Momordica charantia in streptozotocin (STZ)-induced diabetes mellitus in rats. Diabetes mellitus was associated with significant (p < 0.01) time course reductions in body weight, plasma insulin and the number of insulin positive cells per islet and significant (p < 0.01) time course elevation in blood glucose and osmolarity and systolic blood pressure compared to age-matched healthy controls. Oral intake of M. charantia juice by STZ-induced diabetic rats partially reversed all the diabetes-induced effects measured. Daily oral administration of M. charantia juice to STZ-induced diabetic rates significantly (p < 0.01) reduced the Na+- and K+ -dependent absorptions of glucose by the brush border membrane vesicles of the jejunum compared to the responses obtained in STZ-induced diabetic rat. Either insulin (100 MM) or the fruit juice lyophilised extract (5 μg · ml−1) can stimulate 14C-D-glucose uptake in L6 myotubes. These effects were completely blocked by wortmannin, an inhibitor of phosphatidylinositol 3-kinase. High concentrations (10–200 μg · ml-1) of M. charantia juice extract inhibited 14C-D-glucose uptake in L6 myotubes compared to the control response. The effect of M. charantia treatment was also investigated on myelinated fibre abnormalities in the tibial nerve of STZ-induced diabetic and control rats. The results show that diabetes was associated with significant (p < 0.05) reduction in the mean cross-sectional myelinated nerve fibres, axonal area, myelin area and maximal fibre area compared to end controls. Treatment of STZ-induced diabetic rats with M. charantia juice normalised the structural abnormalities of peripheral nerves. The results indicate that M. charantia can exert marked beneficial effects in diabetic rats, and moreover, it can regulate glucose uptake into jejunum membrane brush border vesicles and stimulate glucose uptake into skeletal muscle cells similar to the response obtained with insulin. (Mol Cell Biochem 261: 63–70, 2004)
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zimmet P, Alberti KGMM, Shaw T: Global and societal implications of diabetes epidemic. Nature 414: 782–787, 2001
Bracken P, Singh J, Winlow W, Howarth FC: Mechanism underlying contractile dysfunction in streptozotocin-induced type 1 and type 2 diabetic cardiomyopathy. In: G.M. Pierce, M. Nagano, P. Zahradka, N.S. Dhalla (eds). Atherosclerosis, Hypertension and Diabetes. Kluwer, Boston, 2003, pp. 387–408
Kumar PJ, Clark M: Diabetes mellitus and other disorders of metabolism. In: Textbook of Medicine. Saunders, London, 2002, pp 1069–1121
Karunanayake EH, Tennekoon KH: Search of novel hypoglycaemic agents from medicinal plants. In: A.K. Sharma (ed.). Diabetes Mellitus and Its Complications. An Update, Macmillan India Ltd, New Delhi, India, 1993
Day C, Cartwright T, Provost J, Bailey CJ: Hypoglycaemic effect of Momordica charantia extracts. Planta Med 56: 426–429, 1990
Platel K, Srinivasan K: Plant foods in the management of Diabetes mellitus: Vegetables as potential hypoglycaemic agents. Nahrung 41: 68–74, 1997
Ahmed I: Effects of Momordica charantia fruit juice on experimental diabetes and its complications., University of Central Lancashire, 1999
Sharma AK, Ahmed I, Tadayyon M, Ponery AS, Aloamaka P, Absood G, Pallot DJ: The beneficial effects of Momordica charantia fruit juice on streptozotocin-induced diabetes and hypertension in rats. Int J Diabetes 4: 29–38, 1996
Welihinda J, Karunanayake EH, Sheriff MHR, Jayasinghe KSA: Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 17: 277–282, 1986
Welihinda J, Arvidson G, Gylfe E, Hellman B, Karlesson E: The insulin releasing activity of the tropical plant Momordica charantia. Acta Biol et Med Germ 41: 1229–1240, 1982
Sharma AKK, Thomas PK: Animal models: Pathology and pathophysiology. In: P.J. Dyck, P.K. Thomas, A.K. Asbury, A.I. Winegard, D. Porte (eds). B. Saunders, Philadelpia, 1987
Karunanayake EH, Jeevathayaparan S, Tennekoon KH: Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. J Ethnopharmacol 30: 199–204, 1990
Shirazi-Beechey SP, Davies AG, Tebbutt K, Dyer J, Ellis A, Taylor P, Fairclough P, Beechy RBB: Preparation and properties of brush-border membrane vesicles from human small intestine. Gastroenterology 98: 676–685, 1990
Hundal HS, Ramlal T, Reyes R, Leiter LA, Klip A: Cellular mechanism of metaformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131: 1165–1173, 1992
Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976
Dockery P, Sharma AK: Ultrastructural abnormalities of myelinated fibres in the tibial nerve of streptozotocin-diabetic rats. J Neurol Sci 98: 327–345, 1990
Jeevathayaparan S, Tennekoon KH, Karunanayake EH: A comparative study of the oral hypoglycaemic effect of Momordica charantia fruit juice and tolbutamide in streptozotocin induced graded severity diabetes in the rat. Int J Diabetes 3: 99–108, 1995
Bailey CJ, Day C, Turner SL, Leatherdale BA: Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 2: 81–84, 1985
Sharma AK, Thomas PK, Gabriel G, Stolinski C, Dockery P, Hollins GW: Peripheral nerve abnormalities in the diabetic mutant mouse. Diabetes 32: 1152–1160, 1983
Sidenius P, Jakobsen J: Anterograde fast component of axonal transport during insulin-induced hypoglycaemia in non-diabetic and diabetic rats. Diabetes 36: 853–858, 1987
Thomas PK, Wright DW, Tzebelikos E: Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats. J Neurol Neurosurg Psychiatry 47: 912–916, 1984
Sidenius P, Jakobsen J: Retrograde axonal transport—A possible role in the development of neuropathy. Diabetologia 20: 110–112, 1981
Raza H, Ahmed I, John A, Sharma AK: Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. J Biochem Mol Toxicol 14: 131–139, 2000
Raza H, Ahmed I, Lakhani MS, Sharma AK, Pallot D, Montague W: Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats. Biochem Pharmacol 52: 1639–1642, 1996
Nickmander KK, Schmelzer JD, Rohwer DA, Low PA: Effect of α tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol Sci 126: 6–14, 1994
Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38: 1285–1294, 1995
Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR: Effects of antioxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats: Comparison with essential fatty acids. Diabetologia 38: 129–134, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahmed, I., Adeghate, E., Cummings, E. et al. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem 261, 63–70 (2004). https://doi.org/10.1023/B:MCBI.0000028738.95518.90
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000028738.95518.90